Cargando…
Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
XPO1 (Exportin‐1) is the nuclear export protein responsible for the normal shuttling of several proteins and RNA species between the nucleocytoplasmic compartment of eukaryotic cells. XPO1 recognizes the nuclear export signal (NES) of its cargo proteins to facilitate its export. Alterations of nucle...
Autores principales: | Totiger, Tulasigeri M., Chaudhry, Sana, Musi, Elgilda, Afaghani, Jumana, Montoya, Skye, Owusu‐Ansah, Frank, Lee, Stanley, Schwartz, Gary, Klimek, Virginia, Taylor, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930413/ https://www.ncbi.nlm.nih.gov/pubmed/36722323 http://dx.doi.org/10.1111/jcmm.17667 |
Ejemplares similares
-
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
por: Nguyen, Nina, et al.
Publicado: (2022) -
BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
por: Ambrosini, Grazia, et al.
Publicado: (2015) -
E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2023) -
Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023) -
The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells
por: Ambrosini, Grazia, et al.
Publicado: (2023)